Catalyst Wire Dossier Catalyst Wire Dossier

Human heterologous liver cell infusion

· Cytonet GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human heterologous liver cell infusion, covering 2016-02-08 to 2016-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders [Phase 2]

See pricing